Antibiotic consumption and resistance of gram-negative pathogens (collateral damage)
- PMID: 30671336
- PMCID: PMC6301726
- DOI: 10.3205/id000040
Antibiotic consumption and resistance of gram-negative pathogens (collateral damage)
Abstract
Antibiotics are commonly prescribed in community and hospital care. Overuse and misuse favors emergence and spread of resistant bacteria. The ATC/DDD methodology is commonly used for presenting the drug utilization data. In primary care, the consumption is usually expressed in DDD per 1,000 inhabitants per day, in hospital, preferably in DDD per 100 bed days and DDD per 100 admissions. The alternative metric is days of therapy (DOT), which needs IT support. Antibiotics have ecological adverse effects at individual and population level. Antibiotics select resistant bacteria among pathogens and normal flora. Broad-spectrum antibiotics, low dosage and prolonged antibiotic therapy favor the development of resistance. Although total use of antibiotics in hospital is much less than in the community, the intensity of use magnified by cross infection ensures a multitude of resistant bacteria in today's hospitals. Reversal of resistance is complex and might persist for many years despite the introduction of antimicrobial containment and stewardship programs.
Figures
Similar articles
-
Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience.Front Pharmacol. 2023 Mar 15;14:1067973. doi: 10.3389/fphar.2023.1067973. eCollection 2023. Front Pharmacol. 2023. PMID: 37007038 Free PMC article.
-
Benchmarking of antibiotic usage: An adjustment to reflect antibiotic stewardship program outcome in a hospital in Saudi Arabia.J Infect Public Health. 2018 May-Jun;11(3):310-313. doi: 10.1016/j.jiph.2017.08.008. Epub 2017 Aug 30. J Infect Public Health. 2018. PMID: 28864362 Free PMC article.
-
Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.J Antimicrob Chemother. 2004 May;53(5):853-9. doi: 10.1093/jac/dkh163. Epub 2004 Mar 24. J Antimicrob Chemother. 2004. PMID: 15044426
-
A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings.Br J Clin Pharmacol. 2025 May 28. doi: 10.1002/bcp.70111. Online ahead of print. Br J Clin Pharmacol. 2025. PMID: 40437771 Review.
-
Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017.J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii7-ii13. doi: 10.1093/jac/dkab172. J Antimicrob Chemother. 2021. PMID: 34312654 Free PMC article. Review.
Cited by
-
N-terminal Myristoylation Enhanced the Antimicrobial Activity of Antimicrobial Peptide PMAP-36PW.Front Cell Infect Microbiol. 2020 Aug 27;10:450. doi: 10.3389/fcimb.2020.00450. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32984074 Free PMC article.
-
Lack of Association between Antimicrobial Consumption and Antimicrobial Resistance in a HIV Preexposure Prophylaxis Population: A Cross-Sectional Study.Antibiotics (Basel). 2024 Feb 16;13(2):188. doi: 10.3390/antibiotics13020188. Antibiotics (Basel). 2024. PMID: 38391574 Free PMC article.
-
Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database.Intensive Care Med. 2025 Mar;51(3):518-528. doi: 10.1007/s00134-025-07857-6. Epub 2025 Apr 7. Intensive Care Med. 2025. PMID: 40192823
-
Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors.Drug Healthc Patient Saf. 2024 Jul 23;16:89-101. doi: 10.2147/DHPS.S468966. eCollection 2024. Drug Healthc Patient Saf. 2024. PMID: 39070704 Free PMC article.
-
Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia.Open Forum Infect Dis. 2024 Aug 22;11(9):ofae477. doi: 10.1093/ofid/ofae477. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39263216 Free PMC article.
References
-
- European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publicat....
-
- European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials